BIOKEYS PHARMACEUTICALS, INC.

Company

Savara Inc

Filed

February 6, 2003

Accession Number

0001013594-03-000028

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →